Cargando…

Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study

BACKGROUND: Although the prevalence of hepatitis B in Guangzhou, China, is high, the epidemiological trends are not well-documented. We aimed to analyse newly reported hepatitis B cases in Guangzhou between 2009 and 2020 to explore the epidemiological trends and provide insights for the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Dong, Zhiqiang, Hu, Wensui, Li, Ke, Sun, Lili, Hou, Jianrong, Jia, Shijie, Liu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727992/
https://www.ncbi.nlm.nih.gov/pubmed/36476118
http://dx.doi.org/10.1186/s12879-022-07690-y
_version_ 1784845150117167104
author Liu, Wei
Dong, Zhiqiang
Hu, Wensui
Li, Ke
Sun, Lili
Hou, Jianrong
Jia, Shijie
Liu, Yuan
author_facet Liu, Wei
Dong, Zhiqiang
Hu, Wensui
Li, Ke
Sun, Lili
Hou, Jianrong
Jia, Shijie
Liu, Yuan
author_sort Liu, Wei
collection PubMed
description BACKGROUND: Although the prevalence of hepatitis B in Guangzhou, China, is high, the epidemiological trends are not well-documented. We aimed to analyse newly reported hepatitis B cases in Guangzhou between 2009 and 2020 to explore the epidemiological trends and provide insights for the development of control measures. METHODS: Information on the population and new cases of hepatitis B in Guangzhou between 2009 and 2020 was obtained from the China Information System for Disease Control and Prevention, which was used to calculate the annual notification rates of hepatitis B by sex, age group (0–9; 10–19; 20–29; 30–39; 40–49; 50–59; ≥ 60 years), and location (urban or rural). Joinpoint regression analysis was used to analyse the temporal trends and calculate the average annual percentage change (AAPC) and annual percentage change (APC) for each identified trend line segment. RESULTS: Between 2009 and 2020, 287,034 new cases of hepatitis B were cumulatively reported. The average annual notification rate was 181.13/100,000, and the notification rate showed a long-term downward trend during the period 2009–2020, with an annual decrease of 6.30% (APC − 6.30%; 95% CI − 7.56 to − 5.02%). Men had a significantly higher notification rate than women; however, the sex ratio decreased from a maximum of 2.34 in 2010 to a minimum of 1.54 in 2020. A downward trend in the notification rate was observed in urban areas and an upward trend was observed in rural areas, with an increase in the rural/urban ratio from 0.46 in 2012 to 1.57 in 2020. The notification rate for all age groups showed a decreasing trend from 2009, with the exception of the 50–59 years and ≥ 60 years groups, whose notification rates began to decrease from 2014 and 2015, respectively. CONCLUSIONS: Although the overall notification rate of hepatitis B in Guangzhou decreased annually, it remained high. Further, in rural areas, the notification rate has been increasing, and effective measures should be taken to control hepatitis B infection in Guangzhou.
format Online
Article
Text
id pubmed-9727992
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97279922022-12-08 Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study Liu, Wei Dong, Zhiqiang Hu, Wensui Li, Ke Sun, Lili Hou, Jianrong Jia, Shijie Liu, Yuan BMC Infect Dis Research BACKGROUND: Although the prevalence of hepatitis B in Guangzhou, China, is high, the epidemiological trends are not well-documented. We aimed to analyse newly reported hepatitis B cases in Guangzhou between 2009 and 2020 to explore the epidemiological trends and provide insights for the development of control measures. METHODS: Information on the population and new cases of hepatitis B in Guangzhou between 2009 and 2020 was obtained from the China Information System for Disease Control and Prevention, which was used to calculate the annual notification rates of hepatitis B by sex, age group (0–9; 10–19; 20–29; 30–39; 40–49; 50–59; ≥ 60 years), and location (urban or rural). Joinpoint regression analysis was used to analyse the temporal trends and calculate the average annual percentage change (AAPC) and annual percentage change (APC) for each identified trend line segment. RESULTS: Between 2009 and 2020, 287,034 new cases of hepatitis B were cumulatively reported. The average annual notification rate was 181.13/100,000, and the notification rate showed a long-term downward trend during the period 2009–2020, with an annual decrease of 6.30% (APC − 6.30%; 95% CI − 7.56 to − 5.02%). Men had a significantly higher notification rate than women; however, the sex ratio decreased from a maximum of 2.34 in 2010 to a minimum of 1.54 in 2020. A downward trend in the notification rate was observed in urban areas and an upward trend was observed in rural areas, with an increase in the rural/urban ratio from 0.46 in 2012 to 1.57 in 2020. The notification rate for all age groups showed a decreasing trend from 2009, with the exception of the 50–59 years and ≥ 60 years groups, whose notification rates began to decrease from 2014 and 2015, respectively. CONCLUSIONS: Although the overall notification rate of hepatitis B in Guangzhou decreased annually, it remained high. Further, in rural areas, the notification rate has been increasing, and effective measures should be taken to control hepatitis B infection in Guangzhou. BioMed Central 2022-12-07 /pmc/articles/PMC9727992/ /pubmed/36476118 http://dx.doi.org/10.1186/s12879-022-07690-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Wei
Dong, Zhiqiang
Hu, Wensui
Li, Ke
Sun, Lili
Hou, Jianrong
Jia, Shijie
Liu, Yuan
Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title_full Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title_fullStr Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title_full_unstemmed Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title_short Trends in hepatitis B notification rates in Guangzhou, China, between 2009 and 2020: an epidemiological study
title_sort trends in hepatitis b notification rates in guangzhou, china, between 2009 and 2020: an epidemiological study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727992/
https://www.ncbi.nlm.nih.gov/pubmed/36476118
http://dx.doi.org/10.1186/s12879-022-07690-y
work_keys_str_mv AT liuwei trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT dongzhiqiang trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT huwensui trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT like trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT sunlili trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT houjianrong trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT jiashijie trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy
AT liuyuan trendsinhepatitisbnotificationratesinguangzhouchinabetween2009and2020anepidemiologicalstudy